Barclays raised the firm’s price target on Intuitive Surgical to $385 from $314 and keeps an Overweight rating on the shares. The company delivered a solid earnings beat on stronger than expected procedure growth and strong robot placements, partially offset by higher mix of system leases, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ISRG:
- Intuitive Surgical price target raised to $385 from $315 at Piper Sandler
- Intuitive Surgical price target raised to $360 from $355 at RBC Capital
- Intuitive Surgical price target raised to $386 from $310 at Wells Fargo
- Intuitive Surgical raises FY23 procedure growth view to 20%-22% from 18%-21%
- ISRG Stock Tanks despite Earnings Win